Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Waage

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|May 6, 2020
Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982-2017Øystein O Langseth, Tor Å Myklebust, Tom B Johannesen, et al.
European Journal of Haematology|February 20, 2022
Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based studyØystein O Langseth, Tor Å Myklebust, Tom B Johannesen, et al.
Blood|May 3, 2002
Interleukin-21 is a growth and survival factor for human myeloma cellsAnne-Tove Brenne, Torstein Baade Ro, Anders Waage, et al.
European Journal of Haematology|July 15, 2009
FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14)Thea K Våtsveen, Anne-Tove Brenne, Hong Y Dai, et al.
Haematologica|October 5, 2006
Adult acute lymphoblastic leukemia, Burkitt's lymphoma and lymphoblastic lymphoma in middle Norway 1985-2004Jon Lamvik, Anders Waage, Sissel G Freim Wahl, et al.
European Journal of Haematology|April 7, 2011
Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parametersKarin F Wader, Unn-Merete Fagerli, Randi U Holt, et al.
Haematologica|April 12, 2005
Human myeloma cells adhere to fibronectin in response to hepatocyte growth factorRandi Utne Holt, Vadim Baykov, Torstein Baade Rø, et al.
European Journal of Haematology|July 23, 2013
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunateToril Holien, Oddrun E Olsen, Kristine Misund, et al.
The New England Journal of Medicine|March 8, 2018
A Gain-of-Function Mutation in EPO in Familial ErythrocytosisJakub Zmajkovic, Pontus Lundberg, Ronny Nienhold, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|May 6, 2020
Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982-2017Øystein O Langseth, Tor Å Myklebust, Tom B Johannesen, et al.
European Journal of Haematology|February 20, 2022
Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based studyØystein O Langseth, Tor Å Myklebust, Tom B Johannesen, et al.
Blood|May 3, 2002
Interleukin-21 is a growth and survival factor for human myeloma cellsAnne-Tove Brenne, Torstein Baade Ro, Anders Waage, et al.
European Journal of Haematology|July 15, 2009
FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14)Thea K Våtsveen, Anne-Tove Brenne, Hong Y Dai, et al.
Haematologica|October 5, 2006
Adult acute lymphoblastic leukemia, Burkitt's lymphoma and lymphoblastic lymphoma in middle Norway 1985-2004Jon Lamvik, Anders Waage, Sissel G Freim Wahl, et al.
European Journal of Haematology|April 7, 2011
Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parametersKarin F Wader, Unn-Merete Fagerli, Randi U Holt, et al.
Haematologica|April 12, 2005
Human myeloma cells adhere to fibronectin in response to hepatocyte growth factorRandi Utne Holt, Vadim Baykov, Torstein Baade Rø, et al.
European Journal of Haematology|July 23, 2013
Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunateToril Holien, Oddrun E Olsen, Kristine Misund, et al.
The New England Journal of Medicine|March 8, 2018
A Gain-of-Function Mutation in EPO in Familial ErythrocytosisJakub Zmajkovic, Pontus Lundberg, Ronny Nienhold, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
Pageof 13